Global Human Vaccines Market 2015-2025 | by Disease, End-user & Leading Vaccine with Profiles on Key & Emerging Players

Monday, 21. October 2019 15:41

Dublin, Oct. 21, 2019 (GLOBE NEWSWIRE) -- The "Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential" report has been added to's offering.

The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019-2025.

The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015-2018, and forecasts from 2019 till 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end-users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with a percentage of all the segments.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.

The report concludes with the profiles of the key players in the global human vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines revenue analysis, and recent development.

Other emerging players are making novel technology-based vaccines that are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology and diseases that are seeing vaccines development activity such as infectious diseases, non-infectious diseases, emerging pathogens, and recent development.

The report helps answer the following questions:

  • What is the current size of the overall global human vaccines market? How much will this market be worth from 2019 to 2025?
  • What are the market shares of the leading segments of the global human vaccines market in 2018?
  • What are the main segments of the overall human vaccines market? How much will each of these segments be worth for the period 2015 to 2025?
  • What are the main drivers and restraints in the global human vaccines market?
  • What are the leading vaccines? What are their revenue potentials to 2025?
  • What are the major deals happenings in the global vaccines market?
  • Who are the leading companies and what are their activities, revenue, recent developments, and prospects?
  • What are some of the most prominent human vaccines currently in development? What are their activities, platform technology, and recent developments?
  • What are new disease areas which the vaccines companies are exploring?

Key Topics Covered

1. Executive Summary

2. Global Vaccines Market Size & Forecast (2015-2025)

3. Market Share Analysis of Global Vaccines Market (%)
3.1 Global Vaccines Market Share, By Disease
3.2 Global Vaccines Market Share, By End-user
3.3 Global Vaccines Market Share, By Leading Vaccine
3.4 Global Vaccines Market Share, By Company

4. Global Vaccines Market - Key Market Dynamics
4.1 Key Market Drivers
4.2 Key Market Inhibitors

5. Global Vaccines Market, By Disease
5.1 Pneumococcal Disease
5.2 Diphtheria, Tetanus and Pertussis (DTP)
5.3 Influenza
5.4 Human Papilloma Virus (HPV)
5.5 Meningococcal
5.6 Hepatitis
5.7 Measles, Mumps, and Rubella (MMR)
5.8 Rotavirus
5.9 Varicella
5.10 Other Diseases

6. Global Vaccines Market, By End-user
6.1 Pediatric Vaccines
6.2 Adult Vaccines

7. Global Vaccines Market, By Leading Vaccine
7.1 Prevnar / Prevnar 13
7.2 Gardasil / Gardasil 9
7.3 Vaxigrip
7.4 Fluzone
7.5 Flublok
7.6 Varivax
7.7 Menactra
7.8 Proquad
7.9 Pneumovax 23
7.10 Fluarix/FluLaval
7.11 Havrix/Twinrix/Engerix-B
7.12 Priorix, Priorix Tetra, Varilrix
7.13 M-M-R II
7.14 Adacel
7.15 Boostrix
7.16 Bexsero
7.17 Menveo
7.18 Cervarix
7.19 Trumenba
7.20 Shingrix
7.21 Pentacel, Pentaxim, Imovax, Hexaxim
7.22 Rotateq
7.23 Zostavax
7.24 Rotarix
7.25 Synflorix
7.26 Pediarix, Infanrix
7.27 Ticovac
7.28 Biken Ha
7.29 Tetrabik
7.30 Mearubik
7.31 Varicella (MTP)
7.32 Jebik V
7.33 Flumist/Fluenz
7.34 BioThrax
7.35 Dukoral
7.36 Ixiaro
7.37 InLive
7.38 HeaLive
7.39 BiLive
7.40 Anflu
7.41 EasySix
7.42 Imvamune
7.43 Other Vaccines

8. Major Deals and Agreement Happenings in the Global Vaccines Market
8.1 Merger & Acquisitions
8.2 Collaboration Deal
8.3 Licensing Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement
8.6 Partnerships

9. Key Players in the Global Vaccines Market
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Vaccines Portfolio
9.1.3 Vaccines Market Value Analysis & Forecast
9.1.4 Promising Vaccines in the Clinical Development
9.1.5 Recent Development
9.2 GlaxoSmithKline (GSK)
9.3 Merck
9.4 Pfizer
9.5 AstraZeneca
9.6 Mitsubishi Tanabe Pharma
9.7 Emergent BioSolutions
9.8 Astlellas Pharma Inc.
9.9 Valneva
9.10 Seqirus
9.11 Bavarian Nordic
9.12 Sinovac
9.13 Panacea Biotec
9.14 Bharat Biotech
9.15 Serum Institute of India
9.16 Biological E. Limited

10. Emerging Players in the Global Vaccines Market
10.1 Vaccitech
10.1.1 Business Overview
10.1.2 Promising Vaccines in the Clinical Development
10.1.3 Recent Development
10.2 Janssen (Johnson & Johnson)
10.3 Novavax
10.4 VBI Vaccines
10.5 GeoVax
10.6 Moderna Inc.
10.7 Biondvax
10.8 Integrated Biotherapeutics Inc.
10.9 GeneOne Life Science
10.10 Profectus BioSciences
10.11 Pneumagen
10.12 Themis Bioscience
10.13 Xeme Biopharma Inc.
10.14 Altimmune
10.15 Pfenex Inc.
10.16 Northwest Biotherapeutics
10.17 OncBioMune Pharmaceuticals

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

Related Links: 
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.